CD4 and familial pancreatic carcinoma: To identify the specific mechanism, we first cocultured CD4+CD25− T cells with WT, CD73-overexpressing (OE), and CD73 KO pancreatic cancer cells, and cells treated with TGF-β were used as the positive control.